SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3008AMGN ONXX rumors...mopgcw-6/28/2013
3007Aragon Pharmaceuticals Announces Acquisition by Johnson & Johnson Aragon tonigel bates-6/18/2013
3006From Dow Jones: Several pharmaceutical companies are considering offers for Virsjemmeri-6/17/2013
3005REDWOOD CITY, CALIF., June 10, 2013 - Pearl Therapeutics Inc. today announced thnigel bates-6/10/2013
3004LONDON (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based nigel bates-5/29/2013
3003WCRX up about 25% Actavis Inc. ( ACT ), a big maker of generic drugs that was Ian@SI-5/10/2013
3002Bayer to Buy Conceptus for $1.1 BillionBayer of Germany plans to buy the Americamopgcw-4/29/2013
3001Table of Recent Biotech Buyouts and Premiums (updated for revised VRX-OMPI): siDewDiligence_on_SI14/11/2013
3000Obagi Medical Products, Inc. ( OMPI) (the “Company” or “Obagi”) today announced nigel bates-4/3/2013
2999AZN buys private company Alphacore for an undisclosed sum. uk.finance.yahoo.com nigel bates-4/3/2013
2998Royalty Pharma Announces Proposal To Acquire ElanAnnouncement Made Under Rule 2.sim1-2/25/2013
2997CARY, NC--(Marketwire - Feb 20, 2013) - Cornerstone Therapeutics Inc. ( NASDAQ :nigel bates-2/20/2013
2996Cases where a partnership turned into a buyout: siliconinvestor.comDewDiligence_on_SI-1/22/2013
2995Table of recent biotech buyouts and premiums (updated for AGN-MAPP): siliconinDewDiligence_on_SI-1/22/2013
2994AGN-MAPP at a 60% premium: siliconinvestor.comDewDiligence_on_SI-1/22/2013
2993SAN RAFAEL, Calif., Jan. 7, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Incnigel bates-1/7/2013
2992llumina, Inc. (ILMN) today announced that it has signed a definitive agreement tnigel bates-1/7/2013
2991Gilead Sciences (GILD) and YM BioSciences (YMI) announced that the companies havnigel bates-12/12/2012
2990Cool! But strange. :-)scaram(o)uche-12/10/2012
2989THOUSAND OAKS, Calif. (AP) -- Biotech drug maker Amgen is buying human genetics nigel bates-12/10/2012
2988Ghent, Belgium – 21 September 2012, 7am CET – Devgen nv (Euronext Brussels: DEVGnigel bates-9/21/2012
2987wsj: Valeant Pharmaceuticals International Inc. VRX.T +14.80% has agreed to buy mopgcw-9/4/2012
2986TPG to buy PAR for $50/share.mopgcw-7/16/2012
2985Table of recent biotech buyouts and premiums (updated for HGSI and PRX deals): DewDiligence_on_SI-7/16/2012
2984Table of recent biotech buyouts and premiums (updated for BMY-AMLN deal): silicDewDiligence_on_SI17/11/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News